Literature DB >> 12050114

Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation.

Toru Suzuki1, Junko K-Tsuzuku, Rieko Ajima, Takahisa Nakamura, Yutaka Yoshida, Tadashi Yamamoto.   

Abstract

tob is a member of an emerging family of genes with antiproliferative function. Tob is rapidly phosphorylated at Ser 152, Ser 154, and Ser 164 by Erk1 and Erk2 upon growth-factor stimulation. Oncogenic Ras-induced transformation and growth-factor-induced cell proliferation are efficiently suppressed by mutant Tob that carries alanines but not glutamates, mimicking phosphoserines, at these sites. Wild-type Tob inhibits cell growth when the three serine residues are not phosphorylated but is less inhibitory when the serines are phosphorylated. Because growth of Rb-deficient cells was not affected by Tob, Tob appears to function upstream of Rb. Intriguingly, cyclin D1 expression is elevated in serum-starved tob(-/-) cells. Reintroduction of wild-type Tob and mutant Tob with serine-to-alanine but not to glutamate mutations on the Erk phosphorylation sites in these cells restores the suppression of cyclin D1 expression. Finally, the S-phase population was significantly increased in serum-starved tob(-/-) cells as compared with that in wild-type cells. Thus, Tob inhibits cell growth by suppressing cyclin D1 expression, which is canceled by Erk1- and Erk2-mediated Tob phosphorylation. We propose that Tob is critically involved in the control of early G(1) progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050114      PMCID: PMC186319          DOI: 10.1101/gad.962802

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  53 in total

1.  Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1.

Authors:  B D Strahl; S D Briggs; C J Brame; J A Caldwell; S S Koh; H Ma; R G Cook; J Shabanowitz; D F Hunt; M R Stallcup; C D Allis
Journal:  Curr Biol       Date:  2001-06-26       Impact factor: 10.834

2.  The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation.

Authors:  D Prévôt; T Voeltzel; A M Birot; A P Morel; M C Rostan; J P Magaud; L Corbo
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

3.  Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

Authors:  S Ries; C Biederer; D Woods; O Shifman; S Shirasawa; T Sasazuki; M McMahon; M Oren; F McCormick
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

4.  Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.

Authors:  D Tzachanis; G J Freeman; N Hirano; A A van Puijenbroek; M W Delfs; A Berezovskaya; L M Nadler; V A Boussiotis
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

5.  Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway.

Authors:  D Prévôt; A P Morel; T Voeltzel; M C Rostan; R Rimokh; J P Magaud; L Corbo
Journal:  J Biol Chem       Date:  2001-01-02       Impact factor: 5.157

6.  A serine/threonine kinase p90rsk1 phosphorylates the anti-proliferative protein Tob.

Authors:  T Suzuki; S Matsuda; J K Tsuzuku; Y Yoshida; T Yamamoto
Journal:  Genes Cells       Date:  2001-02       Impact factor: 1.891

7.  Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription.

Authors:  D Guardavaccaro; G Corrente; F Covone; L Micheli; I D'Agnano; G Starace; M Caruso; F Tirone
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

8.  Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor.

Authors:  H Wang; Z Q Huang; L Xia; Q Feng; H Erdjument-Bromage; B D Strahl; S D Briggs; C D Allis; J Wong; P Tempst; Y Zhang
Journal:  Science       Date:  2001-05-31       Impact factor: 47.728

9.  MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells.

Authors:  N Rivard; M J Boucher; C Asselin; G L'Allemain
Journal:  Am J Physiol       Date:  1999-10

10.  Negative regulation of BMP/Smad signaling by Tob in osteoblasts.

Authors:  Y Yoshida; S Tanaka; H Umemori; O Minowa; M Usui; N Ikematsu; E Hosoda; T Imamura; J Kuno; T Yamashita; K Miyazono; M Noda; T Noda; T Yamamoto
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

View more
  44 in total

1.  Differential gene expression in human hepatocellular carcinoma Hep3B cells induced by apoptosis-related gene BNIPL-2.

Authors:  Li Xie; Wen-Xin Qin; Xiang-Huo He; Hui-Qun Shu; Gen-Fu Yao; Da-Fang Wan; Jian-Ren Gu
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

2.  ANA deficiency enhances bone morphogenetic protein-induced ectopic bone formation via transcriptional events.

Authors:  Kentaro Miyai; Mitsuhiro Yoneda; Urara Hasegawa; Sayaka Toita; Yayoi Izu; Hiroaki Hemmi; Tadayoshi Hayata; Yoichi Ezura; Shuki Mizutani; Kohei Miyazono; Kazunari Akiyoshi; Tadashi Yamamoto; Masaki Noda
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

Review 3.  Negative regulators in homeostasis of naïve peripheral T cells.

Authors:  Jaime F Modiano; Lisa D S Johnson; Donald Bellgrau
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  The role of the TOB1 gene in growth suppression of hepatocellular carcinoma.

Authors:  Sheyu Lin; Qingfeng Zhu; Yang Xu; Hui Liu; Junyu Zhang; Jiawei Xu; Honglian Wang; Qing Sang; Qinghe Xing; Jia Fan
Journal:  Oncol Lett       Date:  2012-08-16       Impact factor: 2.967

5.  Inhibition of DNA damage-induced apoptosis through Cdc7-mediated stabilization of Tob.

Authors:  Toru Suzuki; Junko Tsuzuku; Akiyo Hayashi; Yasushi Shiomi; Hiroko Iwanari; Yasuhiro Mochizuki; Takao Hamakubo; Tatsuhiko Kodama; Hideo Nishitani; Hisao Masai; Tadashi Yamamoto
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

6.  Flipping the switch from g1 to s phase with e3 ubiquitin ligases.

Authors:  Lindsay F Rizzardi; Jeanette Gowen Cook
Journal:  Genes Cancer       Date:  2012-11

Review 7.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

8.  Transducer of erbB2.1 is a potential cellular target of gefitinib in lung cancer therapy.

Authors:  Ke-Kang Sun; Yang Yang; Lin Zhao; Li-Li Wang; Yang Jiao
Journal:  Oncol Lett       Date:  2012-10-15       Impact factor: 2.967

9.  Tob1 is a constitutively expressed repressor of liver regeneration.

Authors:  Karen J Ho; Nhue L Do; Hasan H Otu; Martin J Dib; Xianghui Ren; Keiichi Enjyoji; Simon C Robson; Ernest F Terwilliger; Seth J Karp
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

10.  Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis.

Authors:  Michihiko Usui; Yutaka Yoshida; Kunikazu Tsuji; Kaoru Oikawa; Kohei Miyazono; Isao Ishikawa; Tadashi Yamamoto; Akira Nifuji; Masaki Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.